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Abstract
SNAI1 and SNAI2 are transcription factors that initiate Epithelial-to-Mesenchymal cell transitions throughout development
and in cancer metastasis. Here we show novel expression of SNAI1 and SNAI2 throughout mouse preimplantation
development revealing asymmetrical localization of both SNAI1 and SNAI2 in individual blastomeres beginning at the 2-cell
stage through to the 8-cell stage where SNAI1 and SNAI2 are then only detected in outer cells and not inner cells of the
blastocyst. This study implicates SNAI1 and SNAI2 in the lineage segregation of the trophectoderm and inner cell mass, and
provides new insight into these oncogenes.
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regulation of the Na/K-ATPase b1. E-cadherin expression was also
down-regulated resulting in the loss of cell-cell contacts [9].
Conversely, SNAI2 expression promoted Na/K-ATPase b1 subunit
expression by inhibiting SNAI1 expression [9]. Aberrant expression
of SNAI1 [10–13] and SNAI2 [13,14] is also linked to cancer
metastasis in epithelial cell lines through its role in directing epithelialto-mesenchymal cell transition (EMT). SNAI1 and SNAI2 direct the
loss of polarity in epithelial cells by down-regulating E-cadherin
expression resulting in EMT. Once EMT has occurred, a cell is no
longer adherent to its neighbors and re-engages cell proliferation and
metastasis programs [13]. Snai1 knock-out studies in mice have
revealed a role for SNAI1 in neural crest differentiation [10]. Snai2
knock-out mice do not display an embryonic lethality and survive to
birth [15]. Since SNAI1 and SNAI2 are important mediators of Ecadherin and Na/K ATPase b1 subunit expression, (necessary
components for TE differentiation and maintenance), we have
characterized Snai1 and Snai2 expression throughout mouse
preimplantation development and TE differentiation. Our results
have revealed a novel and unexpected protein localization pattern for
SNAI1 and SNAI2 in the 2-cell and 4-cell embryo and have
demonstrated that SNAI1 and SNAI2 become confined solely to the
outer cells, TE cell lineage of the early embryo and are not present in
the inner cell, ICM lineage of the embryo.

Introduction
Preimplantation development is characterized by the differentiation of two distinct cell types, inner cell mass (ICM) which will form
the embryo proper and the trophectoderm (TE) which will
contribute to the embryonic portion of the placenta [1]. The TE
is a polarized, epithelial cell type and the development of the TE is
the first differentiation event to occur throughout mammalian
development. The cell polarity model proposes that TE differentiation is initiated at the 8-cell stage and that TE cell fate occurs
through the establishment of cell polarity along the length of each
blastomere forming an apical and basolateral membrane [1]. If a
blastomere undergoes symmetric division, each daughter cell
inherits equally the apical and basolateral membrane, will remain
polarized, and contribute to the TE [1]. If a blastomere undergoes
asymmetric division, each daughter cell inherits a distinct portion of
the polarized membrane, either apical and basolateral or just
basolateral, resulting in the differentiation of a TE cell and an ICM
cell respectively [1]. Prior to the compacted 8-cell stage in the mouse
however, blastomeres are totipotent and can contribute to all cell
types of the blastocyst [2]. The outer embryonic blastomeres that do
go on to form the TE acquire several critical gene products such as
Na/K-ATPase [3–5], tight junctions [6] and adherens junction,
aquaporins [7], and several transcription factors, such as caudal
homeobox 2 (CDX2) [8] which define the TE cell lineage and
orchestrate its function during blastocyst formation.
Recently, Na/K-ATPase b1 subunit expression has been shown to
be regulated in cell lines by the two TFs, SNAI1 (previously known as
SNAIL) and SNAI2 (previously known as SLUG) [9]. SNAI1
expression was increased in MDCK cells resulting in the downPLoS ONE | www.plosone.org

Results
Quantitative RT-PCR of Snai1 and Snai2 throughout
Preimplantation Development
When quantitative RT-PCR was performed on each developmental stage (1-cell, 2-cell, 4-cell, 8-cell, compacted embryo,
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Snai1 and Snai2 nulls. Whole-mount immunofluorescence and
confocal microscopy were applied to fresh flushed embryos at each
preimplantation developmental stage and revealed a unique
distribution pattern. SNAI1 localization appears in discrete
fluorescent foci in cortical regions throughout the zygote
(Figure 2A). SNAI2 localization is symmetrical however, there
are areas with increased intensity throughout the zygote
(Figure 2B). SNAI1 and SNAI2 protein immunofluorescence
revealed a variety of distribution patterns at the 2-cell stage
including an asymmetrical localization within individual blastomeres. In 6% of 2-cell embryos, SNAI1 was not detectable, while
in 94% of 2-cell embryos SNAI1 was detectable but displayed
variable localization patterns that consisted of either symmetrical
or asymmetrical localization patterns within one or both
blastomeres of a 2-cell embryo (Figure 3A). 16% of 2-cell embryos
displayed a pattern where SNAI1 was asymmetrical in one
blastomere and not expressed in the second blastomere, 9%
displayed symmetrical distribution in one blastomere and no
detection in the second, 16% displayed an asymmetrical and
symmetrical pattern, 25% both asymmetrical and 28% where both
blastomeres displayed symmetrical distribution (Figure 3A). Furthermore, SNAI1 was consistently detectible in the cytoplasm,
however although SNAI1 is a transcription factor, nuclear
localization was not commonly observed.
In contrast, SNAI2 was localized to both the cytoplasm and
nucleus in positive blastomeres throughout preimplantation
development. SNAI2 also displayed both asymmetrical and
symmetrical distribution patterns at the 2-cell stage (Figure 3B).
16% of 2-cell embryos displayed symmetrical cytoplasmic
localization in both blastomeres, in 40% both blastomeres were
asymmetrical and 36% where both blastomeres displayed
symmetrical distribution and weak localization to the nuclei.
8% of 2-cell embryos displayed a pattern where in one blastomere
SNAI2 was asymmetrical, localized to one pole of the
blastomere but not expressed in the nucleus or in the second
blastomere (Figure 3B)
Detection of SNAI1 and SNAI2 at the 4-cell stage also revealed
a variety of distribution patterns, including asymmetrical localization within individual blastomeres (Figures 4A and 4B). Localization patterns included 4-cell embryos expressing SNAI1 in all
blastomeres, 3 of the 4 blastomeres, or only 2 blastomeres
(Figure 4A).
SNAI1 and SNAI2 were detected in the majority of blastomeres
at the 8-cell stage (Figures 5A and 5B respectively). SNAI1 was
either asymmetrically expressed or symmetrically expressed within
an individual 8-cell blastomere, however this pattern was
consistent across all 8-cell embryos. Asymmetrical expression of
SNAI2 was also observed within an individual 8-cell stage
blastomere, however symmetrically distributed SNAI2 was the
most common pattern observed (Figure 5B). In the compacted
embryo, SNAI1 and SNAI2 proteins become confined to the outer
cells only and the inner cells no longer displayed SNAI1 or SNAI2
immunofluorescence (Figures 5A and 5B). This localization
pattern of SNAI1 and SNAI2 persists throughout development
resulting in the detection of SNAI1 and SNAI2 only in the TE of
the blastocyst (Figures 5A and 5B). Cell counts performed at the 8cell, compacted embryo and blastocyst stage revealed the
percentage of SNAI1 and SNAI2 positive cells significantly
decreased as embryos progressed to the blastocyst stage. As the
blastocyst matures and becomes fully expanded, SNAI1 and
SNAI2 were decreasingly detected in all TE cells (filled yellow
arrow indicates positive staining for SNAI1 (Figure 5A) and
SNAI2 (Figure 5B); filled red arrow indicates negative SNAI1 TE
cell (Figure 5A) and negative SNAI2 TE cell (Figure 5B).

blastocyst), it revealed that Snai1 and Snai2 transcripts were
differentially regulated throughout preimplantation development
(Figures 1A and 2A respectively). Snai1 transcripts were detected as
early as the 1-cell stage, and then Snai1 was significantly upregulated at the 2-cell stage followed by down regulation at the 8cell stage and return to baseline levels at the blastocyst stage
(Figure 1A). Detection of Snai1 throughout preimplantation
development confirms previously reported detection by Veltmaat
et al., 2000, however, here we report relative levels of Snai1.
Snai2 transcripts were also detected as early as the 1-cell stage;
however Snai2 transcripts were down regulated at the 2-cell stage
and did not re-accumulate until the 8-cell stage, and increased up
to the blastocyst stage (Figure 1B).

Whole Mount Immunofluoresence of SNAI1 and SNAI2
throughout Preimplantation Development
As revealed by Snai1 knock-out studies, SNAI1 plays a role in
neural crest differentiation during mouse development [10]. Snai2
knock-out mice, alternatively, are able to survive to birth [15].
Although there is no preimplantation lethality in the Snai1 or Snai2
knock-out, the potential does exist that oogenetic proteins are
sufficient to maintain viability past the preimplantation stage in the

Figure 1. Characterization of Snai1 and Snai2 expression. (A)
Snai1 transcripts were detected using quantitative RT-PCR performed
on pools of 20 fresh flushed embryos, at each stage of development (1cell, 2-cell, 4-cell, 8-cell, compacted embryo and blastocyst); n = 3,
p,0.056S.E.M. (B) Snai2 transcripts were detected using quantitative
RT-PCR performed on pools of 20 fresh flushed embryos, at each stage
of development (1-cell, 2-cell, 4-cell, 8-cell, compacted embryo and
blastocyst); n = 3, p,0.056S.E.M.
doi:10.1371/journal.pone.0008530.g001
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Figure 2. Localization of SNAI1 and SNAI2 in the 1-cell Zygote. (A) SNAI1 localization appears in discrete fluorescent foci in cortical regions
throughout the zygote; n = 9. (B) SNAI2 localization is symmetrical however, there are areas with increased intensity throughout the zygote; n = 10.
Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 or SNAI2. Scale bars = 10 mM.
doi:10.1371/journal.pone.0008530.g002

Validation of SNAI1 and SNAI2 Antisera

incubated with peptide pre-absorbed antisera compared to embryos
incubated in non-pre-absorbed antisera alone (Figures S1A and
S1B, respectively). In addition, we knocked down SNAI1 and
SNAI2 by microinjecting siRNA into 1-cell embryos targeting either
Snai1 or Snai2. SNAI1 and SNAI2 were distinctly knocked down but
were still weakly detectable in the siRNA injected embryos. This

Due to the unique nature of the protein localization patterns we
report in our study, we were especially vigilant regarding the
specificity of the antisera employed in this study. Antibody peptide
pre-absorption controls were conducted using preimplantation
embryos. Detection of SNAI1 and SNAI2 was lost in embryos

Figure 3. Representative images of SNAI1 and SNAI2 localization at the 2-cell stage. (A) Embryos were categorized based on SNAI1
localization; n = 32, three replicates. (B) Embryos were categorized based on SNAI2 localization; n = 25, three replicates. Red = Filamentous Actin;
Blue = Nuclei; Green = SNAI1 (A) or SNAI2 (B). Scale bars = 10 mM.
doi:10.1371/journal.pone.0008530.g003
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Figure 4. Representative images of SNAI1 and SNAI2 localization at the 4-cell stage. (A) Embryos were categorized based on SNAI1
localization; n = 15, three replicates. (B) Embryos were categorized based on SNAI2 localization; n = 18, three replicates. Red = Filamentous Actin;
Blue = Nuclei; Green = SNAI1 (A) or SNAI2(B). Scale bars = 10 mM.
doi:10.1371/journal.pone.0008530.g004

reduction of SNAl1 and SNAI2 fluorescence further verifies the
specificity of the antisera employed in this study (Figures S1C and
S1D). We next confirmed the localization patterns of these antisera
in published cell models using the same antisera. SNAI1 and SNAI2
immunofluorescence applied to NIH 3T3 cells demonstrated a
normal (ie nuclear and cytoplasmic distribution) SNAI1 and SNAI2
localization compared to previously published data (Figures S2A
and S2B respectively; (S1C is the negative control)) [17]. We also
applied Western Blot analysis, which revealed single and appropriate sized bands for SNAI1 and SNAI2 (Figure S2D). Furthermore, a
peptide pre-absorption assay was also performed for the Western
blot analysis revealing that the SNAI1 and SNAI2 bands were no
longer detectible using pre-absorbed antisera (Figure S2D). These
experiments conclusively show that the SNAI1 and SNAI2 antisera
employed in this study are specific for SNAI1 and SNAI2,
respectively.
PLoS ONE | www.plosone.org

Discussion
This study sought to characterize the expression of the Snai1 and
Snai2 throughout preimplantation development. Our results have
revealed a novel, asymmetrical protein distribution of SNAI1 and
SNAI2 within the early preimplantation embryo. Snai1 and Snai2
transcripts are detectible throughout preimplantation development.
SNAI1 and SNAI2 have variable expression at the 2-cell and 4-cell
stage including asymmetrical and symmetrical localization within
individual blastomeres. SNAI1 and SNAI2 are detected in the
majority of blastomeres at the 8-cell stage, however, protein
localization varies between blastomeres within a single embryo.
SNAI1 and SNAI2 are then localized to the outer cells in the
compacted embryo and are localized only in TE cells of the blastocyst.
Snai1 pattern of mRNA accumulation does not follow the general
pattern of mRNA transcript expression throughout mouse preim4
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Figure 5. Representative images of SNAI1 and SNAI2 localization at the 8-cell, compacted embryo and blastocyst stage. (A) SNAI1
protein expression pattern at the 8-cell, compacted embryo, and blastocyst stages. The number of blastomeres expressing SNAI1 versus the total
number of blastomeres at each stage was counted. 8-cell (n = 16); Compacted embryo (n = 10); Blastocyst (n = 13); * = p,0.05; *** = p,0.001,
6S.E.M. Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1. Scale bars = 10 mM. (B) SNAI2 protein expression pattern at the 8-cell, compacted
embryo, and blastocyst stages. The number of blastomeres expressing SNAI2 versus the total number of blastomeres at each stage was counted. 8cell (n = 20); Compacted embryo (n = 12); Blastocyst (n = 10); * = p,0.05, 6S.E.M. Red = Filamentous Actin; Blue = Nuclei; Green = SNAI2. Scale bars
= 10 mM.
doi:10.1371/journal.pone.0008530.g005

that Leptin and STAT3 were both asymmetrically expressed in the
oocyte and after fertilization, were subsequently distributed unevenly
to daughter blastomeres at the 4-cell and 8-cell stage. Consequently,
Leptin and STAT3 became distributed in outer cells of the
compacted embryo and then in select cells of the TE, leading to
the hypothesis that Leptin and STAT3 distribution may contribute
to lineage segregation. SNAI1 and SNAI2 are also asymmetrically
localized, however, unlike Leptin and STAT3, are expressed in all
cells of the 8-cell stage and are not asymmetrically expressed in the
outer cells of the compacted embryo or TE of the blastocyst. One
similarity is that SNAI1 and SNAI2, like STAT3 and Leptin are
expressed in certain cells of the TE in the expanded blastocyst, but
not all. It would be interesting to determine if STAT3 and Leptin

plantation development where oogenetic transcripts are largely
degraded by the 2-cell stage and then replaced by embryonic
expression that drives transcript accumulation after the maternal-tozygotic transition occurs [18]. This expression pattern supports a
novel role for SNAI1 during the maternal-to-zygotic transition
(MZT), as its expression is linked closely with the onset of the MZT.
This is further supported by studies conducted in zebrafish that
demonstrate an increase in Snai1 transcript during the onset of MZT
[19]. Snai2 transcripts do decrease at the 2-cell stage and therefore
more closely follow the typical MZT pattern of mRNA transcript
abundance during mouse preimplantation development.
Asymmetrical protein localization in early embryonic blastomeres
has been reported by Antczak and Blerkhome, 1997. They reported
PLoS ONE | www.plosone.org
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and human chorionic gonadotropin (hCG), and mated with CD1
males. Successful mating was determined the next morning (day 1)
by the presence of a vaginal plug. Embryos were collected at
specified times following hCG injection, which correspond to
appropriate cleavage stages: 1-cell inseminated zygotes, 18-hr
post-hCG; 2-cell, 48 hr; 4-cell, 60 hr; 8-cell, 65–68 hr; compacted
embryo, 80–85 hr and blastocysts, 90 hr. Embryos were then
washed in 50 ml M2 media and frozen in groups of 20 for
quantitative RT-PCR analysis or fixed for whole mount
immunofluorescence detection of SNAI1 and SNAI2 proteins.

expression coincided with SNAI1 and SNAI2 expression in the
blastocyst [20]. In other vertebrates and invertebrates asymmetrical
protein expression is more common (ex. Xenopus) [21]. Asymmetrical expression of proteins in other species plays a role in
differentiation by the allocation of that protein to distinct cell
lineages through subsequent cellular divisions [21]. Lineage tracing
studies would have to be performed to determine segregation of
SNAI1 and SNAI2 between the 2-cell to 4-cell division in the mouse
embryo. Furthermore, it has been demonstrated that each
blastomere at the 8-cell stage retains the ability to contribute to all
cell lineages of the early embryo and thus is referred to as being
‘‘totipotent’’ [1]. Our results indicate that blastomeres at the 2-cell, 4cell and 8-cell stages do not all localize SNAI1 or SNAI2 equally and
thus while all early blastomeres may display totipotence, they are not
all equivalent. This variable pattern of SNAI1 and SNAI2
localization may be regulated by the cell cycle as early blastomeres
undergo asynchronous cell divisions. However, the asymmetrical
SNAI1 and SNAI2 localization patterns within individual blastomeres cannot result from cell cycle variation between blastomeres
and likely results from cytoskeletal based mechanisms within the cell.
Our data do not allow us to conclude that SNAI1 or SNAI2 are
active contributors to cell fate decisions during preimplantation
development, but certainly SNAI1 and SNAI2 are markers of cell
fate decisions as their distribution patterns reflect the cell lineage
decisions that occur during the first week of development. It is
intriguing to propose that blastomeres displaying variable SNAI1
and SNAI2 localization patterns may divide in varying planes, which
would produce an uneven inheritance of SNAI1 or SNAI2 to the
daughter blastomeres, and thus contribute to cell fate decisions in the
early embryo. Alternatively, blastomeres that have symmetrical
distribution of SNAI1 or SNAI2 may divide radially, where both
daughter blastomeres would inherit SNAI1 or SNAI2. Our studies
will pursue the determination of the role(s) that SNAI1 and SNAI2
play in preimplantation development and possible cell fate decisions.
It has been proposed that blastomeres at the 2-cell stage are fated to
contribute to the embryonic or abembryonic portion of the embryo
[22]. Furthermore, studies have suggested that 4-cell blastomeres are
not equally pluripotent due to the manner in which 2-cell blastomeres
cleave resulting in an uneven distribution of products across the
blastomeres [23]. Our results demonstrate that SNAI1 and SNAI2
are unevenly distributed at the 2-cell stage and the 4-cell stage,
however, careful analysis has demonstrated that SNAI1 and SNAI2
can be found in all blastomeres at the 4-cell stage regardless of
blastomere position. Furthermore, SNAI1 and SNAI2 are expressed
in all blastomeres at the uncompacted 8-cell stage and are expressed in
all outer cells of the compacted embryo and in both the abembryonic
and embryonic portions of the TE in the expanded blastocyst.
This study reveals asymmetrical distribution of SNAI1 and
SNAI2 as early as the 2-cell and 4-cell stage of preimplantation
development, far earlier than previously thought. Not only are
SNAI1 and SNAI2 asymmetrically distributed within early
cleavage stage blastomeres but their expression is lost in the
ICM coincident with cell lineage specification and the formation
of outer and inner cell lineages in the early embryo. This may
indicate that SNAI1 and SNAI2 may contribute to cell
polarization and epithelial cell differentiation. Collectively, this
study provides novel insight into the potential role of SNAI1 and
SNAI2 in development and cancer metastasis.

Mouse Fibroblast NIH 3T3 Cell Culture
NIH 3T3 cells were plated in 6-well culture dishes at a density
of 56103 cells/cm2. Cells were cultured in complete medium
supplemented with 10% fetal bovine serum (Sigma, St Louis,
MO), 1% Antibiotics (Sigma) in DMEM. Cells were trypsinized
with 1X trypsin for 1 min at 37uC, harvested in 3–5 ml complete
medium and centrifuged for 5 min at 40006g. Cells were resuspended in 10ml complete medium and plated on chamber
slides for immunofluorescence analysis or on 15 cm plates for
protein analysis. Cells were cultured for 2 days until they reached
confluence and fixed for immunofluorescence or lysed for whole
cell lysate collection.

Quantitative RT-PCR
Real-time RT-PCR was conducted to determine the mRNA
profile of Snai1 and Snai2 at the 1-cell, 2-cell, 4-cell, 8-cell,
compacted embryo and blastocyst stages. Prior to RNA extractions, Luciferase mRNA, an exogenous control, was added to the
samples. Total RNA was extracted from pools of 20 embryos using
the PicoPure kit (Arcturus, Molecular Device, Sunnyvale, CA).
Reverse Transcription reaction was carried out using Sensiscript
reverse transcriptase (Qiagen, Mississauga, ON). The samples
were incubated in 10x buffer, RNAse inhibitor, dNTPs and
random primers at 37uC for 1 hour. Quantitative PCR reactions
were performed using the BioRad Chromo4 detection system
(BioRad, Mississauga, ON). PCR was carried out in 25 ml
reactions containing 12.5 ml Multiplex Universal PCR Master
Mix (2X concentration solution optimized for multiplex reactions,
BioRad), 1.25 ul of SNAI1 and SNAI2 primer/probe sets
provided by Biosearch Technologies (Novado, CA), or SYBR
Green (Invitrogen, Burlington, ON) and 5 ml of appropriate
dilution of cDNA (0.1 embryo/ml), and 6.25 ml of water. Snai1
primer sequence 59-CATCCTCGCTGGCATCTTCC-39; 39GAGAGCCAAGCAGGAACCAG-59; Snai2 primer sequence
59-CTTTACCCAGTGGCCTTTCTC-39; 39-CCACAGATCTTGCAGACACAA-59.

Whole-Mount Immunofluorescence
Protein localization was investigated using whole-mount
immunofluorescence methods for both SNAI1 and SNAI2
throughout preimplantation development. Embryos were fixed
in 2% paraformaldehyde in PBS and then incubated in primary
rabbit polyclonal anti-SNAI1 (ab 17732, Abcam, Cambridge, MA
and gift from Dr. Paul Wade and Dr. Archana Dhasarathy) or
rabbit polyclonal anti-SNAI2 antibodies (ab27568, Abcam).
Negative controls were incubated in antibody dilution buffer
alone. NIH 3T3 cells were fixed in 4% paraformaldehyde in PBS
for 20 min. Cells were then washed and incubated with primary
SNAI1 or SNAI2 antibody. Negative control cells were incubated
in antibody dilution buffer alone. Antibody specificity was
determined by conducting immuno-pre-absorption assays with
either a SNAI1 peptide (Abcam) for the SNAI1 antiserum or a
SNAI2 peptide (Abcam) for the SNAI2 antiserum. Fixed embryos

Materials and Methods
Collection of Preimplantation Embryos
Mouse embryos were obtained from random-bred MF1 females
superovulated with pregnant mare’s serum gonadotropin (PMSG)
PLoS ONE | www.plosone.org
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were then incubated in either SNAI1 or SNAI2 antisera alone, or
in the pre-absorption antibody solution. Embryos and cells were
examined by confocal microscopy using an Olympus Fluoview
1000 laser scanning Confocal Microscope (Olympus, Canada). Zstack images were taken of the embryos and used to count total cell
number and SNAI1 or SNAI2 positive cells.

Upon acceptance of normality tests, the data was analyzed using a
One-way ANOVA followed by a Bonferroni multiple comparison
test. If the data failed the normality test, it was analyzed using an
ANOVA on ranks, followed by a Dunn’s multiple comparison test.

Supporting Information
Figure S1 Antisera validation in preimplantation embryo. (A
and B) Antibody pre-absorption assays revealed the specificity of
the SNAI1 (A) and SNAI2 (B) antisera. Embryos incubated in
antisera pre-absorbed with SNAI1 or SNAI2 peptide displayed
comparable levels of SNAI1 or SNAI2 expression with negative
controls. (C and D) Negative siRNA or siRNA targeting Snai1 or
Snai2 was microinjected into 1-cell embryos. Whole-mount
immunofluorescence was applied detecting SNAI1 (F) and SNAI2
(G) in control and knock-down embryos. SNAI1 (F) and SNAI2
(G) expression was significantly down regulated in the embryos
that were microinjected with siRNA targeted to Snai1 or Snai2.
Found at: doi:10.1371/journal.pone.0008530.s001 (5.47 MB TIF)

Western Blot
NIH 3T3 cells were lysed, on ice, using RIPA buffer with
Protease inhibitors. Cells were then scraped into the RIPA buffer
and homogenized by repeated pipetting. Cell lysate was removed
and placed into a 1.5 ml tube and centrifuged at 40006g for 5
min. The supernatant was removed and stored at 280uC. Protein
Quantification was performed using DC Protein Assay kid
(BioRad) and a spectrophotometer. A 12% acrylamide stacking
gel was used and 40 mg of protein was loaded into each lane.
Antiserum dilutions employed included SNAI1 anti-serum
(1:1000); SNAI2 antiserum (1:2000); and secondary antibody
(Anti-Rabbit IgG HRP-linked (Cell Signalling, Danvers, MA) at
1:10000). Antiserum pre-absorption assay was performed prior to
membrane incubation.

Figure S2 Antisera validation in NIH3T3 cells. (A and B)
SNAI1 and SNAI2 antibodies were used to detect SNAI1 (A) and
SNAI2 (B) in NIH3T3 cells (C- no primary control). This
experiment revealed that these antisera replicated the published
localization pattern of SNAI1 and SNAI2 in NIH3T3 cells. (D)
Western Blot analysis was performed to determine the specificity
of the antisera. Single protein bands for both SNAI1 and SNAI2
were detected at the expected molecular weight for each protein.
Protein bands were no longer detected when membranes
were incubated in pre-absorbed SNAI1 and SNAI2 antisera.
Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 or
SNAI2. Scale bars = 10 mM.
Found at: doi:10.1371/journal.pone.0008530.s002 (3.03 MB TIF)

Microinjection of siRNAs
Microinjection was performed under an inverted microscope
using a mechanical micromanipulator (Leica, Richmond Hill, ON,
CA) attached to Picoinjector PLI-100 (Harvard Apparatus, SaintLaurent, PQ, CA). 1-cell embryos were injected with either
negative control (Invitrogen) or siRNA duplexes targeting Snai1 or
Snai2. Microinjection of embryos was performed according to a
standard procedure. One-cell embryos were placed on a concave
watch glass and into KSOMaa medium under light mineral oil. A
holding pipette (Conception Technologies, San Diego, CA) was
used to keep the one-cell embryos stationary during manipulation.
An injection pipette loaded with siRNA solution was inserted into
the cytoplasm of each zygote followed by the microinjection of
approximately 20 pl of 20 mM of dsRNA. After microinjection,
embryos were cultured in KSOMaa medium as described above
for 48 hours and fixed at the 4–8 cell stage and used for wholemount immunofluorescence as described above.
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